ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in December 2021. Updated December 31, 2021 .
A roundup of FDA’s actions in December 2021.
FDA Output December 2021
×
This article is restricted to subscribers only.
To continue reading, select one of the options below:
Existing Subscriber?
Sign In to continue reading.
Need Multi-User Access?
Gain access for your entire organization.
Get Quote Check to see if your company already has accessSubscribe to Market Pathways:
Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.
Subscribe to Market PathwaysSign up for All-Access
Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.
All-Access